Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epistatic interaction between beta2-adrenergic receptor and neuropeptide Y genes influences LDL-cholesterol in hypertension.

Hypertension (Dallas, Tex. : 1979) - 1 Nov 2004

Tomaszewski Maciej, Charchar Fadi J, Lacka Beata, Pesonen Ullamari, Wang William Y S, Zukowska-Szczechowska Ewa, Grzeszczak Wladyslaw, Dominiczak Anna F

Abstract excerpt

Beta2-adrenergic receptor gene and neuropeptide Y gene may potentially influence lipid metabolism and overall energy balance. Therefore, we examined associations of these genes with lipid fractions and obesity-related phenotypes in hypertensive subjects. A total of 638 white individuals from 212 Polish families with clustering of essential hypertension were phenotyped for cardiovascular risk determinants. Each...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholesterol, LDL
Share to Haplotypes

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hypertension

Share to Logistic Models

Share to Neuropeptide Y

Share to Obesity

Share to Pedigree

Share to Receptors, Adrenergic, beta-2

Source

Identifiers

PMID: 15364898
DOI: 10.1161/01.HYP.0000143844.81979.61

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epistatic interaction between beta2-adrenergic receptor and neuropeptide Y genes influences LDL-cholesterol in hypertension.PMID 15364898Read ↗

Association of beta2 adrenergic receptor polymorphisms and related haplotypes with triglyceride and LDL-cholesterol levels.Semantic proximity Read ↗

Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes.Semantic proximity Read ↗

Genetic and Functional Evidence Supports LPAR1 as a Susceptibility Gene for Hypertension.Semantic proximity Read ↗

Association of Neuropeptide Y Gene rs16147 Polymorphism with Cardiovascular Risk Factors, Adipokines, and Metabolic Syndrome in Patients with Obesity.Semantic proximity Read ↗

The Gly16-->Arg16 and Gln27-->Glu27 polymorphisms of beta2-adrenergic receptor are associated with metabolic syndrome in men.Semantic proximity Read ↗

Heredity and cardiometabolic risk: naturally occurring polymorphisms in the human neuropeptide Y(2) receptor promoter disrupt multiple transcriptional response motifs.Semantic proximity Read ↗

Association of ACE2 Polymorphisms and Derived Haplotypes with Obesity and Hyperlipidemia in Female Spanish AdolescentsSemantic proximity Read ↗

Human beta2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white Americans.Semantic proximity Read ↗

Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension.Semantic proximity Read ↗

Polymorphic variants of the beta2-adrenergic receptor (ADRB2) gene and ADRB2-related propanolol-induced dyslipidemia in the Colombian population.Semantic proximity Read ↗

Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels.Semantic proximity Read ↗

Common variants in the beta2-(Gln27Glu) and beta3-(Trp64Arg)--adrenoceptor genes are associated with elevated serum NEFA concentrations and type II diabetes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.